J.P. Morgan once again chose Boston Scientific (New York Stock Exchange:PSX) and surgical intuition )Nasdaq:ISRG) as a top MedTech Big Company Pick for the New Year, and reaffirmed insulin pump maker Insulet (Nasdaq:Podcast) as the best choice for SMID cap.
